Sign Up to like & get
recommendations!
0
Published in 2020 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2020.100574
Abstract: Highlights • High-risk multi-agent drug resistant GTN is a life threatening disease.• Majority of choriocarcinomas show intense PD-L1 immunoreactivity.• Pembrolizumab increases antitumor activity.• Effectiveness of Pembrolizumab in treating patients with high-risk multi-agent drug resistant GTN.
read more here.
Keywords:
case multi;
resistant choriocarcinoma;
multi agent;
drug resistant ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.815917
Abstract: Toripalimab as a novel PD-1 inhibitor has presented its promising efficacy in patients who developed chemo-refractory carcinomas, whereas no study has ever investigated the effectiveness of toripalimab in chemo-resistant choriocarcinoma. Here we reported the effectiveness…
read more here.
Keywords:
resistant choriocarcinoma;
safety;
toripalimab;
patients chemo ... See more keywords